Yuanjie Qiu

Dr. Yuanjie Qiu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
YQYuanjie Qiu
Yuanjie Qiu
YWYan Wang
Yan Wang
NSNirui Shen
Nirui Shen
QWQingting Wang
Qingting Wang
LCLimin Chai
Limin Chai
MLManxiang Li
Manxiang Li
Purpose: High levels of red blood cell distribution width (RDW) and hypoalbuminemia are markers of poor prognosis in chronic obstructive pulmonary disease (COPD) patients. However, few studies have shown that the red blood cell distribution width–albumin ratio (RAR) is related to the mortality of COPD. This study aimed to explore the relationship between RAR and hospital mortality in COPD patients admitted to the intensive care unit (ICU). Patients and Methods: Patients were retrospectively incorporated from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database and divided into two groups by a cutoff value of RAR. Propensity score matching (PSM) was performed to adjust for the imbalance of covariates. Logistic regression models and subgroup analyses were carried out to investigate the relationship between RAR and hospital mortality. The receiver operating characteristic (ROC) curve was used to evaluate the predictive performance of RAR and decision curve analysis (DCA) to assess the clinical utility. Results: In total, 1174 patients were finally identified from the MIMIC-IV database. The cutoff value for RAR was 5.315%/g/dL. After PSM at a 1:1 ratio, 638 patients were included in the matched cohort. In the original and matched cohorts, the high RAR group had higher hospital mortality and longer hospital stays. Logistic regression analysis suggested that RAR was an independent risk factor for hospital mortality. The areas under the ROC curve in the original and matched cohorts were 0.706 and 0.611, respectively, which were larger than applying RDW alone (the original cohort: 0.600, the matched cohort: 0.514). The DCA indicated that RAR had a clinical utility. Conclusion: A higher RAR (> 5.315%/g/dL) was associated with hospital mortality in COPD patients admitted to ICU. As an easily available peripheral blood marker, RAR can predict hospital mortality in critically ill patients with COPD independently. Graphical Abstract:

9 June 2022 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
YQYuanjie Qiu
Yuanjie Qiu
YWYan Wang
Yan Wang
NSNirui Shen
Nirui Shen
QWQingting Wang
Qingting Wang
LCLimin Chai
Limin Chai
MLManxiang Li
Manxiang Li
Background. Chronic obstructive pulmonary disease (COPD) is a common chronic disease. Progression is further exacerbated by the coexistence of cardiovascular disease (CVD). We aim to construct a diagnostic nomogram for predicting the risk of coexisting CVD and a prognostic nomogram for predicting long-term survival in COPD. Methods. The 540 eligible participants selected from the NHANES 20052010 were included in this study. Logistic regression analysis was used to construct a diagnostic nomogram for the diagnosis of coexisting CVD in COPD. Cox regression analyses were used to construct a prognostic nomogram for COPD. A risk stratification system was developed based on the total score generated from the prognostic nomogram. We used C-index and ROC curves to evaluate the discriminant ability of the newly built nomograms. The models were also validated utilizing calibration curves. Survival curves were made using the KaplanMeier method and compared by the Log-rank test. Results. Logistic regression analysis showed that gender, age, neutrophil, RDW, LDH, and HbA1c were independent predictors of coexisting CVD and were included in the diagnostic model. Cox regression analysis indicated that CVD, gender, age, BMI, RDW, albumin, LDH, creatinine, and NLR were independent predictors of COPD prognosis and were incorporated into the prognostic model. The C-index and ROC curves revealed the good discrimination abilities of the models. And the calibration curves implied that the predicted values by the nomograms were in good agreement with the actual observed values. In addition, we found that coexisting with CVD had a worse prognosis compared to those without CVD, and the prognosis of the low-risk group was better than that of the high-risk group in COPD. Conclusions. The nomograms we developed can help clinicians and patients to identify COPD coexisting CVD early and predict the 5-year and 10-year survival rates of COPD patients, which has some clinical practical values.

1 November 2024 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
HHHuizhong Hu
Huizhong Hu
YQYuanjie Qiu
Yuanjie Qiu
NSNirui Shen
Nirui Shen
HCHuan Chen
Huan Chen
JZJia Zhang
Jia Zhang
MLManxiang Li
Manxiang Li
Purpose: Although low-carbohydrate and low-fat diets improve weight loss, cardiovascular disease, and diabetes, the relationship between these dietary patterns, highlighting macronutrient sources, and chronic obstructive pulmonary disease (COPD) remains unclear. This study aimed to assess the association between low-carbohydrate diets (LCDs) and low-fat diets (LFDs) and the odds of COPD and mortality among people with COPD in the National Health and Nutrition Examination Survey. Patients and Methods: Clinical data were extracted from the 2007– 2008, 2009– 2010, and 2011– 2012 National Health and Nutrition Examination Survey (NHANES) cycles that met the inclusion criteria. Multivariable logistic regression was used to evaluate the associations between LCD and LFD scores and COPD, and multivariable Cox proportional hazards regression and restricted cubic spline (RCS) regression were used to assess the relationship between all-cause mortality and LCD and LFD scores. Results: Comparing extreme tertiles, multivariable-adjusted odds ratio (OR) were 1 (reference), 1.09 (95% CI, 0.77– 1.55), 1.84 (95% CI, 1.09– 3.09) (P = 0.045 for trend) for unhealthy LFD scores. After multivariate adjustment, a per 5-point increase in unhealthy LCD score was associated with a 21% higher risk of total mortality (hazard ratio, 1.21; 95% CI, 1.03– 1.43); while a per 5-point increase in healthy LFD scores was associated with a 21% lower risk of total mortality (HR, 0.79; 95% CI, 0.67– 0.94). Conclusion: Higher unhealthy LFD score was associated with an increased odds of COPD. Unhealthy LCD scores were significantly associated with higher total mortality, whereas healthy LFD scores were associated with lower total mortality in patients with COPD.

30 June 2022 in Medicine
Verified
Journal Article
Open access
NSNirui Shen
Nirui Shen
QWQingting Wang
Qingting Wang
YQYuanjie Qiu
Yuanjie Qiu
YWYan Wang
Yan Wang
DLDanyang Li
Danyang Li
MLManxiang Li
Manxiang Li
Background: Regulator of cullins 1 (ROC1) is frequently overexpressed in multiple tumors, and many pieces of research demonstrate that ROC1 is associated with the prognosis and development of a diversity of neoplasms and it is able to serve as a promising prognostic biomarker. Here we performed this meta-analysis to evaluate the prognostic and clinicopathological significance of ROC1 in patients suffering from cancer. Methods: We searched Pubmed, Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and WanFang database. The role of ROC1 in cancers was evaluated by pooled hazard ratios (HRs), odd ratios (ORs) and 95% confidence intervals (CIs). Results: In total, 9 studies including 1002 patients were enrolled in this analysis. The pooled results showed that patients with high expression of ROC1 had poor overall survival (OS) (HR: 2.04, 95% CI: 1.48–2.60, P < 0.001) and recurrence-free survival (RFS) (HR: 1.727, 95% CI: 0.965–2.488, P < 0.001). Additionally, elevated expression of ROC1 was significantly correlated with advanced clinical Tumor Node Metastasis stage (OR: 2.708, 95% CI: 1.856–3.951, P < 0.001), positive lymph node metastasis (OR: 1.968; 95% CI: 1.294–2.993, P = .002), large tumor size (OR: 1.522, 95% CI: 1.079–2.149, P = .017) and poor tumor differentiation (OR: 2.448, 95% CI: 1.793–3.344, P < 0.001). Conclusions: Elevated ROC1 expression predicted worse prognosis and advanced pathological parameters in various cancers. ROC1 was a significant prognostic biomarker for poor survival in human cancers.

1 April 2026 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
YQYuanjie Qiu
Yuanjie Qiu
HHHuizhong Hu
Huizhong Hu
XGXiong Gao
Xiong Gao
JZJia Zhang
Jia Zhang
YMYihan Meng
Yihan Meng
MLManxiang Li
Manxiang Li
Background: Chronic obstructive pulmonary disease (COPD) patients admitted to the intensive care unit (ICU) are usually in serious conditions and have a high hospital mortality rate. Our study aimed to explore simple clinical parameters associated with hospital mortality and to establish a novel prediction model. Methods: Patients were retrospectively screened from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database and the eICU collaborative research database (eICU-CRD). Logistic regression analysis was used to screen clinical parameters associated with hospital mortality in critically ill patients with COPD, and these parameters were used to construct the prediction model presented in the form of a nomogram. The concordance index (C-index), receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) were utilized to evaluate the model. Results: There were 1,174 patients included in the MIMIC-IV database and 3,778 patients available for validation in eICU-CRD. Logistic regression analysis indicated that age (A), leukocyte (L), platelet (P), and red blood cell distribution width-albumin ratio (R) were independent predictors of hospital mortality in critically ill patients with COPD, and the above four predictors were used to construct the ALPR nomogram model. In the ALPR model, the C-index of the establishing set and validation set was 0.759 [95% confidence interval (CI): 0.723–0.794] and 0.717 (95% CI: 0.692–0.742), respectively. ROC and calibration curves also showed good accuracy and discrimination. To a certain extent, the clinical value of the ALPR model was superior to that of the age-adjusted Charlson comorbidity index (CCI) and Sequential Organ Failure Assessment (SOFA) score. Conclusions: The ALPR model can help clinicians predict hospital mortality in critically ill patients with COPD, potentially facilitating personalized treatment.